Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study
Authors:
Open Access
- 12 July 2022
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 40 (9) , 408.e9-408.e18
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Clinical and Economic Implications of Specimen Provenance Complications in Diagnostic Prostate BiopsiesJournal of Urology, 2015
- Incidence and Pathological Features of Prostate Cancer Detected on Transperineal Template Guided Mapping Biopsy After Negative Transrectal Ultrasound Guided BiopsyJournal of Urology, 2013
- Early Detection of Prostate Cancer: AUA GuidelineJournal of Urology, 2013
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2012
- Prostate-Cancer Mortality at 11 Years of Follow-upNew England Journal of Medicine, 2012
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Comparative Analysis of Complexed Prostate Specific Antigen, Free Prostate Specific Antigen and Their Ratio in Detecting Prostate CancerJournal of Urology, 2002
- PROSTATE CANCER DIAGNOSIS USING A SATURATION NEEDLE BIOPSY TECHNIQUE AFTER PREVIOUS NEGATIVE SEXTANT BIOPSIESJournal of Urology, 2001
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- INCIDENCE AND CLINICAL SIGNIFICANCE OF FALSE-NEGATIVE SEXTANT PROSTATE BIOPSIESJournal of Urology, 1998